Abstract
The month of initial detection of tumour was recorded in 2,245 patients with breast cancer and correlated with survival over a follow-up period of 1.5-10 years. Women who initially detected their breast cancer in spring/summer had a significantly longer survival than those detecting their tumour at other times of the year. Overall, this relationship was independent of nodal status, tumour size and hormone receptor status. However, when patients were divided into groups the survival advantage was significantly associated with receptor status and age. Women aged greater than or equal to 50 years with ER-positive and PR-positive tumours who discovered their initial tumour in spring/summer had significantly better survival than those detecting their tumours at other times of the year. Survival was also longer in women aged less than 50 years with receptor-negative tumours who initially found their tumours in spring/summer compared with the rest of the year. This study suggests that the season of first detection of a breast cancer relates significantly to the later behaviour of the tumour, and may reflect seasonal changes in hormone dependent growth.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Cohen P., Wax Y., Modan B. Seasonality in the occurrence of breast cancer. Cancer Res. 1983 Feb;43(2):892–896. [PubMed] [Google Scholar]
- Danforth D. N., Jr, Tamarkin L., Lippman M. E. Melatonin increases oestrogen receptor binding activity of human breast cancer cells. Nature. 1983 Sep 22;305(5932):323–325. doi: 10.1038/305323a0. [DOI] [PubMed] [Google Scholar]
- Danforth D. N., Jr, Tamarkin L., Mulvihill J. J., Bagley C. S., Lippman M. E. Plasma melatonin and the hormone-dependency of human breast cancer. J Clin Oncol. 1985 Jul;3(7):941–948. doi: 10.1200/JCO.1985.3.7.941. [DOI] [PubMed] [Google Scholar]
- Hartveit F., Thoresen S., Tangen M., Halvorsen J. F. Variation in histology and oestrogen receptor content in breast carcinoma related to tumour size and time of presentation. Clin Oncol. 1983 Sep;9(3):233–238. [PubMed] [Google Scholar]
- Hill S. M., Blask D. E. Effects of the pineal hormone melatonin on the proliferation and morphological characteristics of human breast cancer cells (MCF-7) in culture. Cancer Res. 1988 Nov 1;48(21):6121–6126. [PubMed] [Google Scholar]
- Kauppila A., Kivelä A., Pakarinen A., Vakkuri O. Inverse seasonal relationship between melatonin and ovarian activity in humans in a region with a strong seasonal contrast in luminosity. J Clin Endocrinol Metab. 1987 Nov;65(5):823–828. doi: 10.1210/jcem-65-5-823. [DOI] [PubMed] [Google Scholar]
- Kirkham N., Machin D., Cotton D. W., Pike J. M. Seasonality and breast cancer. Eur J Surg Oncol. 1985 Jun;11(2):143–146. [PubMed] [Google Scholar]
- Lee J. A. Seasonal alterations and the natural history of malignant neoplasms. Prog Clin Cancer. 1967;3:96–106. [PubMed] [Google Scholar]
- Mason B. H., Holdaway I. M., Mullins P. R., Kay R. G., Skinner S. J. Seasonal variation in breast cancer detection: correlation with tumour progesterone receptor status. Breast Cancer Res Treat. 1985;5(2):171–176. doi: 10.1007/BF01805991. [DOI] [PubMed] [Google Scholar]
- Mason B. H., Holdaway I. M., Skinner S. J., Stewart A. W., Kay R. G., Neave L. M., Anderson J. Association between season of first detection of breast cancer and disease progression. Breast Cancer Res Treat. 1987;9(3):227–232. doi: 10.1007/BF01806384. [DOI] [PubMed] [Google Scholar]
- Miettinen O. Estimability and estimation in case-referent studies. Am J Epidemiol. 1976 Feb;103(2):226–235. doi: 10.1093/oxfordjournals.aje.a112220. [DOI] [PubMed] [Google Scholar]
- Tamarkin L., Danforth D., Lichter A., DeMoss E., Cohen M., Chabner B., Lippman M. Decreased nocturnal plasma melatonin peak in patients with estrogen receptor positive breast cancer. Science. 1982 May 28;216(4549):1003–1005. doi: 10.1126/science.7079745. [DOI] [PubMed] [Google Scholar]